Business
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Markets Day in Zürich Schlieren (Zürich), Switzerland, May 13, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, is pleased to announce today’s Capital Markets Day on Tuesday, May 13, 2025, at 9am CEST, at the Hyatt Regency Zürich Airport, The Circle, Zürich, Switzerland. The event will also be available virtually via live webcast. Capital Markets Day will
About this update from Kuros Biosciences Ltd.
[{"type":"image","alt":"Kuros Biosciences AG","displaySize":"","headline":null,"caption":"Kuros Biosciences AG","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":53,"url":"https://media.zenfs.com/en/globenewswire.com/53e70503ab3216cc1e8d831966241fc5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JKr5n4LkuMlKdEYCBjLkqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/53e70503ab3216cc1e8d831966241fc5","width":300,"height":53}},"lazy":false},{"type":"text","content":" Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Markets Day in Zürich ","length":117,"tagName":"p"},{"type":"text","content":"Schlieren (Zürich), Switzerland, May 13, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in innovative biologic technologies, is pleased to announce today’s Capital Markets Day on Tuesday, May 13, 2025, at 9am CEST, at the Hyatt Regency Zürich Airport, The Circle, Zürich, Switzerland. The event will also be available virtually via live webcast.","length":359,"tagName":"p"},{"type":"text","content":"Capital Markets Day will provide institutional investors, analysts, and the media with an opportunity to hear directly from the Kuros leadership team about the company’s breakthrough science, global commercial strategy, and transformative approach to bone healing. Attendees will gain valuable insights into the market performance of MagnetOs, its clinical efficacy, and the company’s strategic priorities. Kuros will also provide updates on its expanding global footprint, new market opportunities, and continued innovation in both spinal and extremity applications. Joining the Kuros leadership team will be a U.S. orthopedic surgeon explaining the power of MagnetOs from the surgeon and patient perspective.","length":710,"tagName":"p"},{"type":"text","content":"Key highlights of the presentation will include:","length":48,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"An overview of MagnetOs, Kuros’ proprietary bone healing technology, which has been shown to deliver more predictable fusions in surgical procedures. In a Level I human clinical study published in Spine, MagnetOs demonstrated nearly twice the fusion rate of autograft, with even more significant results among active smokers which is traditionally a h...